Faron, etusivu

releases and announcements

Faron receives EUR 2.1 million funding from BF

Faron selected for EUR2.5 million grant from EIC

MATINS Update

Faron announces R&D Day to be held in June

Faron Pharmaceuticals Oy Harmful association of glucocorticoids in interferon beta-1a treated patients published in Intensive Care Medicine

Results of the Annual General Meeting

Regulatory

Exercise of options

Regulatory

Managers’ transactions

Insider Transaction Regulatory

Faron receives grant from Business Finland

Regulatory

Clevegen manufacturing agreement

Regulatory
PreviousNext
Back to top